Targeted therapy device for multiple myeloma

By designing a targeted therapy device for multiple myeloma with a cylindrical section, an injection section, and a control section, the problem of inaccurate drug injection speed and dosage control in existing technologies has been solved, achieving safe and controllable drug injection, adapting to changes in patient weight, and improving treatment efficacy.

CN119034058AInactive Publication Date: 2024-11-29THE FIRST AFFILIATED HOSPITAL OF HEBEI NORTH UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410945422.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-15
Publication Date
2024-11-29
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing targeted therapy devices for multiple myeloma cannot precisely control the speed and dosage of drug injection, leading to cardiotoxicity, pulmonary toxicity, and liver damage, and are unable to adapt to changes in patient weight.

Method used

A targeted therapy device comprising a cylindrical section, an injection section, and a control section was designed. By controlling the opening and closing of the vent through an initiation component and a rate limiting component, the drug injection speed can be precisely regulated, avoiding leakage and excessively rapid injection.

Benefits of technology

It achieves controllable and safe drug injection speed, conforms to the injection standards based on patient weight, avoids cardiotoxicity, pulmonary toxicity and liver damage, and ensures that the drug fully reaches the target tissue in the body.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119034058A_ABST
    Figure CN119034058A_ABST
Patent Text Reader

Abstract

The invention discloses a targeted therapy device for multiple myeloma, and relates to the technical field of medical instruments, the targeted therapy device for multiple myeloma comprises a cylinder part, a push injection part and a control part, when the targeted therapy device is used, a pressing handle is pulled, so that an annular cylinder is upwards separated from a fixing frame, an air hole is communicated with the outside through an air groove, and to-be-injected medicine for targeted therapy of multiple myeloma is extracted; the pressing handle is pressed to be close to the upper handle, and the air groove is blocked by the sliding barrel and the connecting rod in the fixing frame; after the pressing handle is close to the upper handle, the annular cylinder is downwards separated from the fixing frame, but the lower side of the annular cylinder enters the air hole, the side hole in the annular cylinder does not enter the air hole, and the space between the outer cylinder and the needle cylinder still cannot be communicated with the outside through the air hole. The thumb pushes the shifting block on the pressing handle to enable the rotating wheel to rotate to pull the pull rope, and the pull rope enables the connecting rod to upwards compress the lower spring and expose the side hole. The space between the needle cylinder and the outer cylinder is communicated with the outside through the air hole, the annular cylinder, the side hole, the air groove, the fixing frame and the side groove.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of medical devices, and in particular to a targeted treatment device for multiple myeloma. Background Art

[0002] Multiple myeloma is a malignant plasma cell disease, the cause of which is related to viral infection, long-term exposure to radiation and other factors. Common treatments include chemotherapy, radiotherapy and stem cell transplantation. Targeted therapy for multiple myeloma is an effective treatment method. Targeted therapy for multiple myeloma mainly relies on targeted drugs such as monoclonal antibodies. These drugs can block toxic cell signals, kill tumor cells, regulate the body's immunity, and restore the key functions of immune effector cells. Specific drugs include bortezomib for injection, carfilzomib injection, cyclophosphamide tablets, etc. These drugs can inhibit the growth of tumor cells and prevent the tumor from continuing to grow and affecting bone marrow hematopoiesis and other functions. Targeted therapy is effective and can prevent multiple myeloma from further aggravation to a large extent. Targeted drugs using CD38 monoclonal antibodies can further improve the therapeutic effects of chemotherapy, proteasome inhibitors, and immunosuppressants, and relieve the symptoms of multiple myeloma; the dosage of targeted drugs usually needs to be adjusted according to the patient's weight, condition, and genetic test results; taking bortezomib as an example, it is a proteasome inhibitor that is administered by intravenous injection and usually needs to be used with dexamethasone to reduce adverse reactions; for patients with malignant myeloma, intravenous infusion is usually used to administer the drug; this method can directly deliver the drug into the patient's blood, allowing the drug to take effect faster.

[0003] In summary, the current treatment process for multiple myeloma has the following technical problems: When targeted therapy is administered by intravenous injection, the patient's condition often causes a sharp drop in weight, including bortezomib (Velcade): 1.3 mg / m 2 , subcutaneous injection or intravenous injection, usually on days 1, 4, 8, and 11, with a 21-day cycle; Carfilzomib (Kyprolis): initial dose: 20 mg / m 2 , intravenous injection, given on days 1 and 2, if tolerated, the dose is increased to 27 mg / m 2, administered on days 8, 9, 15, and 16, and repeated in a 28-day cycle; Daratumumab (Darzalex): 16 mg / kg, intravenous injection, once a week in the first cycle, once every two weeks from the second to sixth cycles, and once every four weeks starting from the seventh cycle; Elotuzumab (Empliciti): 10 mg / kg, intravenous injection, once a week in the first and second cycles, and once every two weeks starting from the third cycle, used in combination with other drugs; the above doses are calculated based on the patient's weight. Under normal circumstances, too fast an infusion rate may cause myocardial toxicity or pulmonary toxicity; resulting in the destruction of liposomes and the release of drugs too fast, making it impossible for the drugs to fully reach the target tissues in the body, thereby reducing the therapeutic effect; for liver-targeted drug delivery, too fast an injection rate and too large a volume will increase mechanical damage to the liver, and increased solution pressure will also increase liver damage; it is necessary to accurately control the patient's injection volume and injection rate. The existing CN 209827824U A targeted treatment device for multiple myeloma can only control the step-by-step change of dosage through the cooperation of a set card block and a limit groove, and cannot adapt to the precise value of the patient's weight. Summary of the invention

[0004] In view of the above problems existing in the prior art, the present invention provides a targeted treatment device for multiple myeloma.

[0005] In order to achieve the above technical objectives and the above technical effects, the present invention is implemented through the following technical solutions:

[0006] A targeted treatment device for multiple myeloma comprises a barrel, a push-injection unit and a control unit, wherein the barrel comprises an outer barrel and a syringe, wherein the outer barrel is fixedly connected to the lower side of the syringe, and an annular groove is formed between the syringe and the outer barrel; the push-injection unit comprises an inner barrel, a piston and an upper handle, wherein the inner barrel and the piston are fixedly connected to the upper handle, wherein the piston is slidably connected in the syringe, wherein the inner barrel is slidably connected in the outer barrel, and wherein the inner barrel is provided with an air hole parallel to its own axis; wherein the upper handle is provided with a control unit, wherein the control unit comprises a starting component and a speed limiting component, wherein the air hole position is provided with a starting component for changing the air hole to an open state and a closed state, and wherein the starting component is provided with a speed limiting component for adjusting the size of the air hole in the open state to ventilate the air to the outside.

[0007] Furthermore, the push handle is provided with an air groove, the air groove corresponds to the air hole, the air groove is communicated with the air hole, the starting assembly includes a push handle, a sliding column is fixedly connected to the lower side of the push handle, a sliding hole matching the sliding column is provided on the upper handle, an upper spring is fixedly connected between the push handle and the upper handle; the push handle is provided with a side groove at a position corresponding to the position of the air groove, the push handle is fixedly connected to a fixing seat in the side groove, a ring cylinder is provided on the lower side of the fixing seat, and the upper handle is fixedly connected to a fixing frame on the upper side of the air groove position; the upper part of the ring cylinder is slidably connected in the fixing frame, a connecting rod is provided in the middle between the push handle and the ring cylinder; a fixing column is fixedly connected to one side between the push handle and the ring cylinder; the diameter of the ring cylinder is the same as the diameter of the air hole.

[0008] Furthermore, the upper end of the connecting rod is slidably connected in the fixing seat, a lower spring is fixedly connected between the connecting rod and the fixing seat, the lower end of the connecting rod is slidably connected in the annular tube, the annular tube is located at the lower side of the fixing frame and has an air hole, and the lower end of the connecting rod blocks the air hole;

[0009] The speed limiting assembly includes a rotating wheel, a rotating shaft, a shift block and a pull rope. The middle of the push handle is fixedly connected to the rotating shaft, the rotating wheel is rotatably connected to the rotating shaft, the upper side of the rotating wheel is fixedly connected to the rotating wheel, and a pull rope is fixedly connected between the connecting rod and the rotating wheel.

[0010] Furthermore, the side groove extends toward the edge of the handle at the position corresponding to the air hole, the height of the fixing seat is less than the thickness of the handle, and the handle is located on the upper side of the side groove;

[0011] The upper handle is sealed and connected to the inner cylinder at the lower side of the air groove;

[0012] The rotating shaft is arranged horizontally, and the axial direction of the rotating shaft is perpendicular to the direction in which the connecting rod points to the center of the circle;

[0013] The upper handle is provided with a through hole at a position corresponding to the syringe, and the push handle is provided with a through groove at a position corresponding to the through hole, so that the movement of the plunger is not hindered by air pressure.

[0014] Furthermore, a lower plate is fixedly connected to the lower side of the sliding column.

[0015] Beneficial effects of the present invention:

[0016] A targeted treatment device for multiple myeloma. When in use, the handle is pulled to make the ring tube detach upward from the fixing frame, and the air hole is connected to the outside world through the air groove, and the targeted treatment drug for multiple myeloma to be injected is extracted. When performing intravenous injection, the handle is pressed to make the handle approach the upper handle. Since the sliding tube and the connecting rod block the air groove in the fixing frame, no leakage will occur when not in use, and no excessive movements are required when in use; after the handle is close to the upper handle, the ring tube detaches downward from the fixing frame, but the lower side of the ring tube enters the air hole, and the side hole on the ring tube does not enter the air hole. The space between the outer tube and the syringe still cannot be connected to the outside world through the air hole. The thumb pushes the dial block on the handle to rotate the rotating wheel to pull the pull rope, and the pull rope pulls the connecting rod upward The lower spring is compressed and the side hole is exposed. The space between the syringe and the outer cylinder is connected to the outside world through the air hole, the ring tube, the side hole, the air groove, the fixing frame and the side groove, and then the injection is carried out. During the injection process, the overlap degree of the rotating wheel and the side hole can be controlled, and the size of the space for gas flow can be controlled, thereby controlling the injection speed. During the operation, it is necessary to control the injection method of the dial block, which can avoid the problem of too fast injection speed due to too much force in the process of pressing the handle, and avoid the problem of the ring tube being separated from the fixing frame due to accidental pressing of the handle, so that the injection is safe and there will be no leakage. The injection speed is controllable and will not be too fast when just injected. At the same time, the operator can control the injection to stop at any time, which meets the requirements of the injection standard converted into milligram level according to the patient's weight.

[0017] Of course, any product implementing the present invention does not necessarily need to achieve all of the advantages described above at the same time. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the accompanying drawings required for describing the embodiments will be briefly introduced below. Obviously, the accompanying drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other accompanying drawings can be obtained based on these accompanying drawings without paying creative work.

[0019] Figure 1 This is a schematic diagram of the overall structure of the targeted treatment device for multiple myeloma according to an embodiment of the present invention;

[0020] Figure 2 This is a schematic diagram of the structural connection between the outer cylinder and the syringe according to an embodiment of the present invention;

[0021] Figure 3 This is a schematic diagram of the lower structural connection between the outer cylinder and the syringe according to an embodiment of the present invention;

[0022] Figure 4 This is a schematic diagram of the structural connection between the inner cylinder and the handle according to an embodiment of the present invention;

[0023] Figure 5This is a schematic diagram of the connection between the inner cylinder and the lower structure of the handle according to an embodiment of the present invention;

[0024] Figure 6 It is a schematic diagram of the structural connection of the cross section of the injection unit and the control unit according to the embodiment of the present invention;

[0025] Figure 7 This is a schematic diagram of the structural connection between the inner cylinder and the upper handle according to an embodiment of the present invention;

[0026] Figure 8 This is a schematic diagram of the lower structural connection of the upper handle according to an embodiment of the present invention;

[0027] Fig. 9 This is a schematic diagram of the structural connection between the handle and the fixing seat according to an embodiment of the present invention;

[0028] Fig.10 It is a schematic diagram of the cross-sectional structure connection of the push handle, upper handle and inner tube according to an embodiment of the present invention;

[0029] Fig.11 A schematic diagram of the structural connection of the control unit according to an embodiment of the present invention;

[0030] Fig.12 It is a schematic diagram of the cross-sectional structure connection of the fixing frame, the slide cylinder, the fixing seat and the handle according to the embodiment of the present invention;

[0031] In the accompanying drawings, the components represented by the reference numerals are listed as follows:

[0032] 1-outer cylinder, 101-syringe, 2-inner cylinder, 201-air hole, 202-upper handle, 203-air groove, 204-through hole, 205-sliding hole, 210-piston, 220-fixed frame, 3-handle, 301-side groove, 302-through groove, 303-sliding column, 304-lower plate, 305-middle spring, 310-fixed seat, 311-ring cylinder, 312-side hole, 313-connecting rod, 314-lower spring, 315-fixed column, 320-rotating wheel, 321-rotating shaft, 322-shift block, 323-pull rope. DETAILED DESCRIPTION

[0033] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0034] The technical solution of the present invention is described in detail below in conjunction with specific embodiments:

[0035] Example 1

[0036] like Figure 1-12 Shown

[0037] The targeted treatment device for multiple myeloma of the present invention comprises a barrel, an injection unit and a control unit. The barrel comprises an outer barrel (1) and a syringe (101). The outer barrel (1) is fixedly connected to the lower side of the syringe (101), and an annular groove is formed between the syringe (101) and the outer barrel (1). The injection unit comprises an inner barrel (2), a piston (210) and an upper handle (202). The inner barrel (2) and the piston (210) are fixedly connected to the upper handle (202). The piston (210) is 0) is slidably connected in the syringe (101), the inner cylinder (2) is slidably connected in the outer cylinder (1), the inner cylinder (2) is provided with an air hole (201) parallel to its own axis; the upper handle (202) is provided with a control unit, the control unit includes a starting component and a speed limiting component, the air hole (201) is provided with a starting component for changing the air hole (201) between an open state and a closed state, and the starting component is provided with a speed limiting component for adjusting the size of the air hole (201) in the open state to ventilate the outside;

[0038] The push handle (3) is provided with an air groove (203), the air groove (203) corresponds to the air hole (201), the air groove (203) is communicated with the air hole (201), the starting assembly comprises a push handle (3), a sliding column (303) is fixedly connected to the lower side of the push handle (3), a sliding hole (205) matching with the sliding column (303) is provided on the upper handle (202), an upper spring is fixedly connected between the push handle (3) and the upper handle (202); the push handle (3) is provided with a side groove (301) at a position corresponding to the position of the air groove (203), the push handle (3) is fixedly connected with a fixing seat (303) in the side groove (301), 10), a ring tube (311) is provided at the lower side of the fixing seat (310), and the upper handle (202) is fixedly connected to a fixing frame (220) at the upper side of the air groove (203); the upper part of the ring tube (311) is slidably connected in the fixing frame (220), and a connecting rod (313) is provided in the middle between the push handle (3) and the ring tube (311); a fixing column (315) is fixedly connected to one side between the push handle (3) and the ring tube (311); the diameter of the ring tube (311) is the same as the diameter of the air hole (201); and the lower side of the sliding column (303) is fixedly connected to a lower plate (304) to prevent the push handle from being separated from the upper handle.

[0039] Example 2

[0040] like Figure 9-12 Shown

[0041] The upper end of the connecting rod (313) is slidably connected in the fixing seat (310), a lower spring (314) is fixedly connected between the connecting rod (313) and the fixing seat (310), the lower end of the connecting rod (313) is slidably connected in the ring tube (311), the ring tube (311) is located at the lower side of the fixing frame (220) and has an air hole (201), and the lower end of the connecting rod (313) blocks the air hole (201); the speed limiting component comprises a rotating wheel (320), a rotating shaft (321), a shifting block (322) and a pull rope (323), the middle of the push handle (3) is fixedly connected with a rotating shaft (321), a rotating wheel (320) is rotatably connected on the rotating shaft (321), the upper side of the rotating wheel (320) is fixedly connected with a rotating wheel (320), and a pull rope (323) is fixedly connected between the connecting rod (313) and the rotating wheel (320);

[0042] The side groove (301) extends toward the edge of the handle (3) at a position corresponding to the air hole (201); the height of the fixing seat (310) is less than the thickness of the handle (3); and the handle (3) is located on the upper side of the side groove (301);

[0043] The upper handle (202) is sealedly connected to the inner cylinder (2) at the lower side of the air groove (203);

[0044] The rotating shaft (321) is arranged horizontally, and the axial direction of the rotating shaft (321) is perpendicular to the direction of the connecting rod (313) pointing to the center of the circle;

[0045] The upper handle (202) is provided with a through hole (204) at a position corresponding to the syringe (101), and the push handle (3) is provided with a through groove (302) at a position corresponding to the through hole (204), so that the movement of the plunger is not hindered by air pressure.

[0046] In summary, the invention provides a targeted treatment device for multiple myeloma. When in use, the handle is pulled to make the ring tube detach upward from the fixing frame, and the air hole is connected to the outside world through the air groove, and the targeted treatment drug to be injected for multiple myeloma is extracted. When performing intravenous injection, the handle is pressed to make the handle approach the upper handle. Since the sliding tube and the connecting rod block the air groove in the fixing frame, no leakage will occur when not in use, and no excessive movements are required when in use. After the handle is close to the upper handle, the ring tube detaches downward from the fixing frame, but the lower side of the ring tube enters the air hole, and the side hole on the ring tube does not enter the air hole. The space between the outer tube and the syringe still cannot be connected to the outside world through the air hole. The thumb pushes the dial block on the handle to rotate the rotating wheel to pull the pull rope, and the pull rope connects The connecting rod compresses the lower spring upward and exposes the side hole. The space between the syringe and the outer cylinder is connected to the outside world through the air hole, the ring tube, the side hole, the air groove, the fixing frame and the side groove, and then the injection is performed. During the injection process, the overlap degree of the rotating wheel and the side hole can be controlled, and the size of the space for gas flow can be controlled, thereby controlling the injection speed. During the operation, it is necessary to control the injection method of the dial block, which can avoid the problem of too fast injection speed due to a large force during the process of pressing the handle, and avoid the problem of the ring tube being separated from the fixing frame due to accidental pressing of the handle, so that the injection is safe and will not leak. The injection speed is controllable and will not be too fast when just injected. At the same time, the operator can control the injection stop at any time, which meets the requirements of the injection standard of milligram level converted according to the patient's weight;

[0047] After the thumb covers the handle through the side grooves and through grooves, internal ventilation is still maintained without restricting the attachment position of the thumb;

[0048] The syringe is provided with the dimensions of the prior art to help the operator for reference. The input speed is limited and the limit can be stopped at any time to control the input amount and input rate. It is manually controlled by the operator and requires a charging light to operate, avoiding the need for various charging and maintenance preparations before the operation. The instrument is reliably controlled and will not cause problems such as inoperability due to insufficient energy during use.

[0049] In the description of this specification, the description with reference to the terms "one embodiment", "example", "specific example", etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described can be combined in any one or more embodiments or examples in a suitable manner.

[0050] The preferred embodiments of the present invention disclosed above are only used to help illustrate the present invention. The preferred embodiments do not describe all the details in detail, nor do they limit the invention to the specific implementation methods described. Obviously, many modifications and changes can be made according to the content of this specification. This specification selects and specifically describes these embodiments in order to better explain the principles and practical applications of the present invention, so that those skilled in the art can understand and use the present invention well. The present invention is limited only by the claims and their full scope and equivalents.

Claims

1. A targeted treatment device for multiple myeloma, characterized in that: It includes a barrel, a push-injection part and a control part, the barrel includes an outer barrel and a syringe, the outer barrel is fixedly connected to the lower side of the syringe, and an annular groove is formed between the syringe and the outer barrel; the push-injection part includes an inner barrel, a piston and an upper handle, the inner barrel and the piston are fixedly connected to the upper handle, the piston is slidably connected in the syringe, the inner barrel is slidably connected in the outer barrel, and the inner barrel is provided with an air hole parallel to its own axis; the upper handle is provided with a control part, the control part includes a starting component and a speed limiting component, the air hole position is provided with a starting component for changing the air hole to an open and closed state, and the starting component is provided with a speed limiting component for adjusting the size of the air hole in the open state to ventilate the outside.

2. The targeted treatment device for multiple myeloma according to claim 1, characterized in that: The push handle is provided with an air groove, and the air groove corresponds to the air hole, and the air groove is communicated with the air hole. The starting assembly includes a push handle, and a sliding column is fixedly connected to the lower side of the push handle, and a sliding hole matching the sliding column is provided on the upper handle, and an upper spring is fixedly connected between the push handle and the upper handle; the push handle is provided with a side groove at a position corresponding to the position of the air groove, and the push handle is fixedly connected with a fixing seat in the side groove, a ring cylinder is provided on the lower side of the fixing seat, and the upper handle is fixedly connected with a fixing frame on the upper side of the air groove position; the upper part of the ring cylinder is slidably connected in the fixing frame, and a connecting rod is provided in the middle between the push handle and the ring cylinder; a fixing column is fixedly connected to one side between the push handle and the ring cylinder; the diameter of the ring cylinder is the same as the diameter of the air hole.

3. The targeted treatment device for multiple myeloma according to claim 2, characterized in that: The upper end of the connecting rod is slidably connected in the fixing seat, a lower spring is fixedly connected between the connecting rod and the fixing seat, the lower end of the connecting rod is slidably connected in the annular tube, the annular tube is located at the lower side of the fixing frame and has an air hole, and the lower end of the connecting rod blocks the air hole; The speed limiting assembly includes a rotating wheel, a rotating shaft, a shifting block and a pull rope, the middle of the handle is fixedly connected with a rotating shaft, the rotating shaft is rotatably connected with a rotating wheel, the upper side of the rotating wheel is fixedly connected with a rotating wheel, and a pull rope is fixedly connected between the connecting rod and the rotating wheel.

4. The targeted treatment device for multiple myeloma according to claim 3, characterized in that: The upper handle is provided with a through hole at a position corresponding to the syringe, and the push handle is provided with a through groove at a position corresponding to the through hole.

5. The targeted treatment device for multiple myeloma according to claim 4, characterized in that: A lower plate is fixedly connected to the lower side of the sliding column.